These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 1321290)

  • 1. Interaction of the human papillomavirus type 16 E6 oncoprotein with wild-type and mutant human p53 proteins.
    Scheffner M; Takahashi T; Huibregtse JM; Minna JD; Howley PM
    J Virol; 1992 Aug; 66(8):5100-5. PubMed ID: 1321290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53.
    Scheffner M; Werness BA; Huibregtse JM; Levine AJ; Howley PM
    Cell; 1990 Dec; 63(6):1129-36. PubMed ID: 2175676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Degradation of p53 can be targeted by HPV E6 sequences distinct from those required for p53 binding and trans-activation.
    Crook T; Tidy JA; Vousden KH
    Cell; 1991 Nov; 67(3):547-56. PubMed ID: 1657399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The domain of p53 required for binding HPV 16 E6 is separable from the degradation domain.
    Mansur CP; Marcus B; Dalal S; Androphy EJ
    Oncogene; 1995 Feb; 10(3):457-65. PubMed ID: 7845670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of human papillomavirus type 18 (HPV-18) E6-mediated degradation of p53 in vitro and in vivo reveals significant differences based on p53 structure and cell type but little difference with respect to mutants of HPV-18 E6.
    Gardiol D; Banks L
    J Gen Virol; 1998 Aug; 79 ( Pt 8)():1963-70. PubMed ID: 9714244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The ability of human papillomavirus E6 proteins to target p53 for degradation in vivo correlates with their ability to abrogate actinomycin D-induced growth arrest.
    Foster SA; Demers GW; Etscheid BG; Galloway DA
    J Virol; 1994 Sep; 68(9):5698-705. PubMed ID: 8057451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical co-expression of human papillomavirus type 16/18 transforming (E6) oncoprotein and p53 tumour suppressor gene proteins in oesophageal cancer.
    Agarwal SK; Chatterji A; Bhambhani S; Sharma BK
    Indian J Exp Biol; 1998 Jun; 36(6):559-63. PubMed ID: 9731468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The human papillomavirus type 16 E6 oncoprotein can down-regulate p53 activity by targeting the transcriptional coactivator CBP/p300.
    Zimmermann H; Degenkolbe R; Bernard HU; O'Connor MJ
    J Virol; 1999 Aug; 73(8):6209-19. PubMed ID: 10400710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular steady-state levels of "high risk" but not "low risk" human papillomavirus (HPV) E6 proteins are increased by inhibition of proteasome-dependent degradation independent of their p53- and E6AP-binding capabilities.
    Kehmeier E; Rühl H; Voland B; Stöppler MC; Androphy E; Stöppler H
    Virology; 2002 Jul; 299(1):72-87. PubMed ID: 12167343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-risk human papillomavirus E6 protein has two distinct binding sites within p53, of which only one determines degradation.
    Li X; Coffino P
    J Virol; 1996 Jul; 70(7):4509-16. PubMed ID: 8676476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure of the E6/E6AP/p53 complex required for HPV-mediated degradation of p53.
    Martinez-Zapien D; Ruiz FX; Poirson J; Mitschler A; Ramirez J; Forster A; Cousido-Siah A; Masson M; Vande Pol S; Podjarny A; Travé G; Zanier K
    Nature; 2016 Jan; 529(7587):541-5. PubMed ID: 26789255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cloning and expression of the cDNA for E6-AP, a protein that mediates the interaction of the human papillomavirus E6 oncoprotein with p53.
    Huibregtse JM; Scheffner M; Howley PM
    Mol Cell Biol; 1993 Feb; 13(2):775-84. PubMed ID: 8380895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Papillomavirus E6 PDZ interactions can be replaced by repression of p53 to promote episomal human papillomavirus genome maintenance.
    Brimer N; Vande Pol SB
    J Virol; 2014 Mar; 88(5):3027-30. PubMed ID: 24352452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted degradation of the retinoblastoma protein by human papillomavirus E7-E6 fusion proteins.
    Scheffner M; Münger K; Huibregtse JM; Howley PM
    EMBO J; 1992 Jul; 11(7):2425-31. PubMed ID: 1321031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The E6 variant proteins E6I-E6IV of human papillomavirus 16: expression in cell free systems and bacteria and study of their interaction with p53.
    Shally M; Alloul N; Jackman A; Muller M; Gissmann L; Sherman L
    Virus Res; 1996 Jun; 42(1-2):81-96. PubMed ID: 8806176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A cellular protein mediates association of p53 with the E6 oncoprotein of human papillomavirus types 16 or 18.
    Huibregtse JM; Scheffner M; Howley PM
    EMBO J; 1991 Dec; 10(13):4129-35. PubMed ID: 1661671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interference of proteins involved in the cytoplasmic sequestration of p53 with human papillomavirus E6-mediated degradation.
    Isaacs JS; Barrett JC; Weissman BE
    Mol Carcinog; 1999 Jan; 24(1):70-7. PubMed ID: 10029413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutational analysis of human papillomavirus type 16 E6 protein: transforming function for human cells and degradation of p53 in vitro.
    Nakagawa S; Watanabe S; Yoshikawa H; Taketani Y; Yoshiike K; Kanda T
    Virology; 1995 Oct; 212(2):535-42. PubMed ID: 7571423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple regions of E6AP (UBE3A) contribute to interaction with papillomavirus E6 proteins and the activation of ubiquitin ligase activity.
    Drews CM; Brimer N; Vande Pol SB
    PLoS Pathog; 2020 Jan; 16(1):e1008295. PubMed ID: 31971989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple functions of human papillomavirus type 16 E6 contribute to the immortalization of mammary epithelial cells.
    Liu Y; Chen JJ; Gao Q; Dalal S; Hong Y; Mansur CP; Band V; Androphy EJ
    J Virol; 1999 Sep; 73(9):7297-307. PubMed ID: 10438818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.